2016 Genitourinary Cancers Symposium

The American Society of Clinical Oncology’s 2016 Genitourinary Cancers Symposium was held earlier this month (January 7-9) in San Francisco, California, where the brightest professionals in urology, oncology, and obstetrics and gynecology gathered to share some of the newest research on care for genitourinary cancers. Journal of Clinical Pathways hightlights the top presentations from the conference. 

Cabozantinib Bests Everolimus for Treatment of Advanced Renal Cell Carcinoma

• Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current standard treatment.

Racial Differences in Treatment Decision-Making Patterns and Decisional Regret in Patients with Localized Prostate Cancer

• Researchers found ia significant difference in the treatment decisions made by Caucasian and African American patients.

Digital Health Application for Real-Time Patient-Reported Outcomes During Prostate Radiotherapy

• Mobile applications that enable patients to self-report quality of life changes in real time could be useful during cancer treatment and for clinical trials.

Active Surveillance: How to Measure, Manage, and Improve

• Using proper selection criteria can better facilitate institutional adoption of active surveillance. 

Small Cell Carcinoma of the Bladder: Comparison of Survival in Various Treatment Modalities at Fox Chase Cancer Center (FCCC) from 1995 to 2015

• Presenters revealed findings from a 10-year study analyzing the effectiveness of different treatment options for bladder cancer.

Recovery After Surgery and Care Coordination Pathway at City of Hope: Length of Stay, Readmissions, and Complications

• A pathway for bladder cancer developed at City of Hope (Duarte, CA) helped to reduce patient length of stay without increasing complications or readmission rates.

Simulation in Oncologic care: Advancing Evidence-Based Decisions in the Management of Metastatic Castration Resistant Prostate Cancer

• An online education system for physicians may be able to improve decision-making, quality of care, and patient outcomes.

The Impact of Subsequent Metastasis on Medical Costs in Medicare Patients with Prostate Cancer

• According to results from a study, metastasis in Medicare beneficiaries with prostate cancer can produce significant cost increases for patients and healthcare systems.

Cost-Effectiveness Analysis of Initial Management Strategies for Low-Risk Prostate Cancer

• Presenters shared the results of a multifaceted analysis of the different care strategies available to providers for the treatment of low-risk prostate cancer.

Comparisons of Outcomes for Patients with High-Risk Prostate Cancer Treated with Brachytherapy, External Beam Radiation, or Radical Prostatectomy

• Researchers presented data from a study to determine the best treatment for patients with high-risk prostate cancer.